Skip to main content
Clinical Trials/NCT03797768
NCT03797768
Unknown
Not Applicable

Protocol for Community-based Management of Chronic Obstructive Pulmonary Disease in Nepal: a Community-based Cluster Randomized Controlled Trial

University of Aarhus1 site in 1 country1,438 target enrollmentDecember 25, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
University of Aarhus
Enrollment
1438
Locations
1
Primary Endpoint
Forced Expiratory Volume in 1 second
Last Updated
5 years ago

Overview

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is the fourth most important cause of death worldwide and is one of the commonest non-communicable diseases (NCDs) in Nepal. The presence of risk factors like indoor and outdoor air pollution, the high prevalence of smoking and lack of general awareness of COPD makes it a serious public health concern. However, no attempt has been made in Nepal to estimate its burden and address the disease at the community level. This community-based cluster randomized controlled study aims to fulfil that gap through mobilization of Female Community Health Workers (FCHVs) who will be trained to perform a certain set of health promotion activities aimed at prevention of the disease and its progression. Baseline and follow-up surveys will be conducted to compare the intervention and control groups. This study has the potential to generate evidence in helping address NCDs in Nepal and also other similar resource-limited countries.

Registry
clinicaltrials.gov
Start Date
December 25, 2019
End Date
September 30, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Capable of performing spirometry
  • Aged greater than and equal to 40 years
  • Full time residents in the study area and will be in the study area for at least one year

Exclusion Criteria

  • Younger than 40 years of age
  • Self-reported pregnancy
  • having active pulmonary tuberculosis or being on medications for pulmonary tuberculosis
  • thoracic, abdominal or eye surgery in the last six months
  • History of Mental illness
  • MI in past 8 weeks prior to study
  • Hospital admission in the past six months for cardiac illness
  • Those who decline to provide consent to the study will be excluded.

Outcomes

Primary Outcomes

Forced Expiratory Volume in 1 second

Time Frame: 1 year

Mean difference in FVE1 between intervention and control arm

Secondary Outcomes

  • Proportion of risk factors of COPD between intervention and control arm(1 year)

Study Sites (1)

Loading locations...

Similar Trials